Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

● The company has a good ESG score relative to its sector, according to Refinitiv.


Strengths

● The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.

● The company shows low valuation levels, with an enterprise value at 0.28 times its sales.

● The company's share price in relation to its net book value makes it look relatively cheap.

● The company has a low valuation given the cash flows generated by its activity.

● Over the last twelve months, the sales forecast has been frequently revised upwards.

● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.

● Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.

● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.


Weaknesses

● According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.

● The company's earnings growth outlook lacks momentum and is a weakness.

● For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.

● For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.

● Over the past four months, analysts' average price target has been revised downwards significantly.

● The overall consensus opinion of analysts has deteriorated sharply over the past four months.

● The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.